CDLX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cardlytics Inc (CDLX) is not a strong buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with declining revenue, net income, and EPS. Additionally, technical indicators suggest a bearish trend, and there are no significant positive catalysts or trading signals to support a buy decision. It is recommended to hold off on investing in this stock until stronger financial and market indicators emerge.
The MACD is positive and expanding, suggesting slight bullish momentum. However, the RSI is neutral at 43.001, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 0.929, with key support at 0.845 and resistance at 1.013. Overall, the technical indicators point to a bearish trend.
Hedge funds are significantly increasing their buying activity, with a 361.26% increase over the last quarter.
Insiders are selling heavily, with a 267.10% increase in selling activity over the last month. Financial performance is weak, with declining revenue, net income, and EPS. No recent news or congress trading data is available to provide additional support.
In Q3 2025, revenue dropped by -22.41% YoY to $52.03M, net income fell by -49.94% YoY to -$72.67M, and EPS decreased by -53.10% YoY to -1.36. Gross margin improved slightly to 45.27%, up 3.21% YoY. Overall, the company's financial performance is poor.
No data available for analyst ratings or price target changes.
